Zobrazeno 1 - 10
of 575
pro vyhledávání: '"O. Alfthan"'
Publikováno v:
Journal of Urology. 163:317-322
Purpose: To study short-term events in the mechanism of action of BCG with an emphasis on the interaction between BCG and T24 cell line cells. Materials and Methods: Peripheral blood mononuclear cells (PBMNC) or/and several tumor cell lines were incu
Publikováno v:
World Journal of Urology. 15:89-95
A survey on superficial, local urinary bladder cancer, its prognostic factors, and instillation treatments is presented on the basis of experience with approximately 1,000 patients over a period of 20 years, experimental investigations, and the liter
Publikováno v:
Journal of Urology. 154:2050-2053
Purpose: Our aim was to prove if alternating chemotherapeutic and immunotherapeutic instillations improved efficacy and reduced toxicity in patients with carcinoma in situ of the bladder.Materials and Methods: Of 68 carcinoma in situ patients randoml
Publikováno v:
Urological Research. 21:235-238
The aim of the present study was to examine the suitability of biodegradable polymers as materials for a urethral stent. A new urethral stent made of biodegradable self-reinforced poly-L-lactide (SR-PLLA) was implanted in 16 male rabbits after urethr
Autor:
I. Elomaa, T. Kylmälä, T. Tammela, J. Viitanen, J. Ottelin, M. Ruutu, K. Jauhiainen, M. Ala-Opas, L. Roos, J. Seppänen, O. Alfthan
Publikováno v:
International Urology and Nephrology. 24:159-166
Although osteosclerotic metastases are characteristic of prostatic carcinoma, bone resorption is also accelerated. Since clodronate inhibits bone resorption and relieves bone pain, we have given it to patients with painful bone disease from prostatic
Autor:
Reijo Haapiainen, Sakari Rannikko, M. Saarialho, M. Ala-Opas, J. Permi, J. K. Viitanen, Harri Juusela, O. Alfthan, Mirja Ruutu, Hansson E
Publikováno v:
British Journal of Urology. 67:184-187
The primary clinical efficacy of orchiectomy and the combination therapy of intramuscular polyoestradiol phosphate 80 mg monthly and oral ethinyl oestradiol 0.15 mg daily was evaluated by progression and cancer mortality rates in a series of 277 pros
Publikováno v:
European Urology. 19:12-15
We compared the effect and toxicity of estramustine phosphate and weekly low-dose epirubicin in a prospective randomized trial in 41 patients with metastatic prostate cancer refractory to hormonal manipulation. No significant difference between treat
Publikováno v:
British Journal of Urology. 66:94-97
Summary— The primary clinical efficacy of orchiectomy and polyoestradiol phosphate (PEP) 160 mg/month i.m. was evaluated by progression and cancer mortality rates in a Finnish multicentre study comprising 200 prostatic cancer patients. After the mi
Publikováno v:
International Urology and Nephrology. 22:263-269
In the treatment of 38 patients with urethral stricture, 21 received intralesional corticosteroid injections, combined in 17 cases with internal urethrotomy. The aetiology of the lesion is discussed, together with a review of the pertaining literatur
Autor:
Sakari Rannikko, P. E. J. Voutilainen, Ulf-Håkan Stenman, K. Liewendahl, O. Alfthan, E. J. Permi, Reijo Haapiainen
Publikováno v:
British Journal of Urology. 65:264-267
Serum acid phosphatase activity (ACP), prostate specific phosphatase (PAP) and prostate specific antigen (PSA) were measured in 100 patients with prostatic cancer. The patients were divided into 4 groups: T1-2 MO, T3-4 MO and M1 patients with less th